NWSA
77
6
ROP
54
4
VLO
46
3
SCHW
78
14
IR
61
4
GD
53
4
LOW
49
4
BF.B
48
2
EXR
55
4
RIG
32
4
ISRG
71
4
SYF
72
7
FLR
72
7
BIIB
46
3
CMCSA
46
4
DVN
29
2
AAL
36
3
BXP
49
8
MS
74
4
PSX
35
3
NWSA
77
6
ROP
54
4
VLO
46
3
SCHW
78
14
IR
61
4
GD
53
4
LOW
49
4
BF.B
48
2
EXR
55
4
RIG
32
4
ISRG
71
4
SYF
72
7
FLR
72
7
BIIB
46
3
CMCSA
46
4
DVN
29
2
AAL
36
3
BXP
49
8
MS
74
4
PSX
35
3
Financhill
Back

Goldman Sachs ActiveBeta US Large Cap Equity ETF Vs. Viking Therapeutics Industry Stock Comparison

Buy
82

GSLC
Goldman Sachs ActiveBeta US Large Cap Equity ETF

Last Price:
$116.19
Seasonality Move:
6.07%
Sell
48

VKTX
Viking Therapeutics

Last Price:
$27.19
Seasonality Move:
5.13%
Buy
82
Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC) is a Buy

Is Goldman Sachs ActiveBeta US Large Cap Equity ETF a Buy, Sell or Hold?

  • The current Goldman Sachs ActiveBeta US Large Cap Equity ETF [GSLC] share price is $116.22. The Score for GSLC is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • GSLC is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
48
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $27.18. The Score for VKTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GSLC Stock Price Chart

What is Goldman Sachs ActiveBeta US Large Cap Equity ETF's stock price today?

  • The Goldman Sachs ActiveBeta US Large Cap Equity ETF share price today is $116.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GSLC is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $27.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.

GSLC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.95 Buy
Relative Strength Index (14 RSI): 62.17 Buy
Chaikin Money Flow: 294487 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (108.38 - 115.9) Buy
Bollinger Bands (100): (107.92 - 118.54) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.3 Buy
Relative Strength Index (14 RSI): 50.03 Buy
Chaikin Money Flow: -66940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.26 - 28.6) Sell
Bollinger Bands (100): (24.75 - 34.65) Sell

GSLC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 115.98 Buy
20-day SMA: 113.48 Buy
50-day SMA: 109.74 Buy
200-day SMA: 113.37 Buy
8-day EMA: 115.3 Buy
20-day EMA: 113.51 Buy
50-day EMA: 111.91 Buy
200-day EMA: 111.28 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.64 Sell
20-day SMA: 27.9 Sell
50-day SMA: 26.31 Buy
200-day SMA: 44.33 Sell
8-day EMA: 27.48 Sell
20-day EMA: 27.31 Sell
50-day EMA: 27.72 Sell
200-day EMA: 38.01 Sell

Goldman Sachs ActiveBeta US Large Cap Equity ETF Earnings Growth & GSLC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.28 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.64 per share.

Goldman Sachs ActiveBeta US Large Cap Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):